| |
| |
|
| Insider
Information: |
Rakin Kevin |
| Relationship: |
|
| City: |
New Haven |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
522,967 |
|
|
Indirect Shares
|
7,152,757 |
|
|
| Direct
Value |
$211,241 |
|
|
|
Indirect Value
|
$2,153,771 |
|
|
| Total
Shares |
7,675,724 |
|
|
| Total
Value |
$2,365,012 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -81.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clinical Data Inc |
CLDA |
Director |
2006-11-20 |
29,926 |
2006-11-20 |
6,500 |
Premium* |
|
|
Vion Pharmaceuticals Inc |
VIONQ |
Director |
2008-12-11 |
7,229 |
2007-01-15 |
0 |
Premium* |
|
|
Ocugen Ord Shs |
OCGN |
Director |
2019-02-08 |
418,639 |
2019-02-08 |
257,846 |
Premium* |
|
|
Oramed Pharmaceuticals Inc |
ORMP |
Director |
2022-03-21 |
46,661 |
2016-12-01 |
0 |
Premium* |
|
|
Aziyo Biologics, Inc. |
AZYO |
Director, 10% Owner |
|
0 |
2022-12-05 |
5,688,411 |
Premium* |
|
|
Highcape Capital Acquisition Corp. |
QSI |
|
2022-12-20 |
20,512 |
2022-12-20 |
1,200,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| QSI |
Highcape Capital Acquisit... |
|
• • – |
2022-12-15 |
4 |
S |
$2.15 |
$191,234 |
I/I |
(89,000) |
1,801,000 |
0 |
% |
|
| QSI |
Highcape Capital Acquisit... |
|
• • – |
2022-12-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(601,000) |
1,200,000 |
0 |
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • – |
2005-10-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
37,966 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • – |
2005-10-07 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,500 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • – |
2005-11-17 |
4 |
A |
$19.56 |
$48,906 |
D/D |
2,500 |
40,466 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • – |
2006-08-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
540 |
39,926 |
|
- |
|
| CLDA |
Clinical Data Inc |
Director |
– • – |
2006-11-20 |
4 |
S |
$16.13 |
$161,815 |
D/D |
(10,000) |
29,926 |
0 |
- |
|
| VIONQ |
Vion Pharmaceuticals Inc |
Director |
– • – |
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
34,700 |
34,700 |
0 |
- |
|
| VIONQ |
Vion Pharmaceuticals Inc |
Director |
– • – |
2007-03-13 |
4 |
B |
$1.59 |
$23,850 |
D/D |
15,000 |
49,700 |
2.39 |
- |
|
| VIONQ |
Vion Pharmaceuticals Inc |
Director |
– • – |
2007-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
11,300 |
61,000 |
0 |
- |
|
| VIONQ |
Vion Pharmaceuticals Inc |
Director |
– • – |
2008-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,130 |
7,229 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2014-12-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,209 |
|
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2014-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
10,358 |
45,983 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2014-12-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(89) |
35,625 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2014-12-08 |
4 |
B |
$11.00 |
$74,162 |
D/D |
6,742 |
35,714 |
2.39 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2014-12-08 |
4 |
S |
$11.00 |
$187 |
D/D |
(17) |
28,972 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2014-12-08 |
4 |
OE |
$0.76 |
$184 |
D/D |
242 |
28,989 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2014-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
15,538 |
28,747 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2014-12-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(58) |
50,420 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2014-12-08 |
4 |
B |
$11.00 |
$49,445 |
I/I |
4,495 |
50,478 |
2.1 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2016-09-29 |
4 |
A |
$2.25 |
$79,607 |
I/I |
35,381 |
85,800 |
0 |
- |
|
| OCGN |
Ocugen Ord Shs |
Director |
– • – |
2016-11-30 |
4 |
A |
$0.00 |
$0 |
I/I |
142,396 |
228,196 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2016-12-01 |
4 |
A |
$6.08 |
$13,371 |
D/D |
2,200 |
2,200 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2016-12-02 |
4 |
A |
$6.21 |
$45,057 |
D/D |
7,261 |
9,461 |
0 |
- |
|
| ORMP |
Oramed Pharmaceuticals In... |
Director |
– • – |
2016-12-05 |
4 |
A |
$6.38 |
$14,665 |
D/D |
2,300 |
11,761 |
0 |
- |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
